Scinai Immunotherapeutics (SCNI) Gains from Sales and Divestitures (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Scinai Immunotherapeutics (SCNI) has disclosed Gains from Sales and Divestitures for 2 consecutive years, with $26974.0 as the latest value for Q4 2025.

• Quarterly Gains from Sales and Divestitures rose 69.72% to $26974.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26974.0 through Dec 2025, up 69.72% year-over-year, with the annual reading at $26974.0 for FY2025, 69.72% up from the prior year.
• Gains from Sales and Divestitures hit $26974.0 in Q4 2025 for Scinai Immunotherapeutics, up from $15893.0 in the prior quarter.
• In the past five years, Gains from Sales and Divestitures ranged from a high of $26974.0 in Q4 2025 to a low of $15893.0 in Q4 2024.

Peer Comparison